Stay updated on Pimavanserin Relapse Prevention Clinical Trial

Sign up to get notified when there's something new on the Pimavanserin Relapse Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pimavanserin Relapse Prevention Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site footer’s revision identifier was updated from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T15:50:01.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A site-wide notice says NIH websites are transitioning to use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with updates and FAQs available.
    Difference
    0.5%
    Check dated 2026-10-25T15:43:25.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T20:51:03.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov release label changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T20:56:34.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    New revision entry v3.7.0 added to the study history, updating from the previous v3.6.6. This represents a page revision in the record history rather than changes to trial data or outcomes.
    Difference
    0.1%
    Check dated 2026-09-20T19:46:50.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the study record history and the previous v3.6.5 entry was removed, indicating a recent update to the version history.
    Difference
    0.1%
    Check dated 2026-08-30T08:36:01.000Z thumbnail image

Stay in the know with updates to Pimavanserin Relapse Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pimavanserin Relapse Prevention Clinical Trial page.